Annotation Detail for ANP32A
Basic Information Top
Gene Symbol: | ANP32A ( C15orf1,I1PP2A,LANP,MAPM,MGC119787,MGC150373,PHAP1,PHAPI,PP32 ) |
---|---|
Gene Full Name: | acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
Band: | 15q23 |
Quick Links | Entrez ID:8125; OMIM: 600832; Uniprot ID:AN32A_HUMAN; ENSEMBL ID: ENSG00000140350; HGNC ID: 13233 |
Relate to Another Database: | SFARIGene; denovo-db |
- Unigene ID: Hs.458747
Pool Name | Gene EST/Total EST in pool | Transcripts per million(TPM) | Bar based on TPM |
---|---|---|---|
embryoid body | 15 / 70761 | 211 | |
blastocyst | 10 / 62319 | 160 | |
fetus | 70 / 564012 | 124 | |
neonate | 0 / 31097 | 0 | |
infant | 11 / 23620 | 465 | |
juvenile | 16 / 55556 | 287 | |
adult | 183 / 1939121 | 94 |
Pool Name | Gene EST/Total EST in pool | Transcripts per million(TPM) | Bar based on TPM |
---|---|---|---|
adrenal tumor | 3 / 12794 | 234 | |
bladder carcinoma | 1 / 17475 | 57 | |
breast (mammary gland) tumor | 10 / 94178 | 106 | |
cervical tumor | 9 / 34366 | 261 | |
chondrosarcoma | 7 / 82823 | 84 | |
colorectal tumor | 16 / 114246 | 140 | |
esophageal tumor | 4 / 17290 | 231 | |
gastrointestinal tumor | 14 / 119369 | 117 | |
germ cell tumor | 43 / 263845 | 162 | |
glioma | 3 / 106883 | 28 | |
head and neck tumor | 13 / 136302 | 95 | |
kidney tumor | 7 / 68959 | 101 | |
leukemia | 15 / 95842 | 156 | |
liver tumor | 14 / 96359 | 145 | |
lung tumor | 9 / 103127 | 87 | |
lymphoma | 22 / 71755 | 306 | |
non-neoplasia | 2 / 97250 | 20 | |
normal | 366 / 3360307 | 108 | |
ovarian tumor | 6 / 76682 | 78 | |
pancreatic tumor | 6 / 104616 | 57 | |
primitive neuroectodermal tumor of the CNS | 34 / 125680 | 270 | |
prostate cancer | 8 / 102680 | 77 | |
retinoblastoma | 10 / 46356 | 215 | |
skin tumor | 7 / 124949 | 56 | |
soft tissue/muscle tissue tumor | 6 / 125191 | 47 | |
uterine tumor | 19 / 90257 | 210 |
Pool Name | Gene EST/Total EST in pool | Transcripts per million(TPM) | Bar based on TPM |
---|---|---|---|
adipose tissue | 1 / 13106 | 76 | |
adrenal gland | 3 / 33197 | 90 | |
ascites | 10 / 40015 | 249 | |
bladder | 10 / 29757 | 336 | |
blood | 13 / 123478 | 105 | |
bone | 5 / 71655 | 69 | |
bone marrow | 7 / 48801 | 143 | |
brain | 96 / 1100989 | 87 | |
cervix | 9 / 48171 | 186 | |
connective tissue | 8 / 149255 | 53 | |
ear | 4 / 16212 | 246 | |
embryonic tissue | 58 / 215722 | 268 | |
esophagus | 4 / 20209 | 197 | |
eye | 31 / 211054 | 146 | |
heart | 18 / 89626 | 200 | |
intestine | 27 / 234472 | 115 | |
kidney | 23 / 211777 | 108 | |
larynx | 7 / 24145 | 289 | |
liver | 23 / 207743 | 110 | |
lung | 28 / 336974 | 83 | |
lymph | 16 / 44270 | 361 | |
lymph node | 8 / 91610 | 87 | |
mammary gland | 18 / 153271 | 117 | |
mouth | 3 / 67052 | 44 | |
muscle | 7 / 107715 | 64 | |
nerve | 2 / 15768 | 126 | |
ovary | 9 / 102051 | 88 | |
pancreas | 10 / 214812 | 46 | |
parathyroid | 0 / 20539 | 0 | |
pharynx | 2 / 41328 | 48 | |
pituitary gland | 4 / 16585 | 241 | |
placenta | 32 / 280825 | 113 | |
prostate | 17 / 189345 | 89 | |
salivary gland | 2 / 20155 | 99 | |
skin | 13 / 210574 | 61 | |
spleen | 7 / 53952 | 129 | |
stomach | 4 / 96619 | 41 | |
testis | 22 / 330442 | 66 | |
thymus | 12 / 81131 | 147 | |
thyroid | 5 / 47473 | 105 | |
tonsil | 1 / 16999 | 58 | |
trachea | 1 / 52413 | 19 | |
umbilical cord | 0 / 13680 | 0 | |
uterus | 26 / 232878 | 111 | |
vascular | 4 / 51780 | 77 |
- Microarray Platform: GeneAtlas U133A, gcrma
- Affymatrix Probe ID: 201043_s_at
Cell line | Expression level | Expression bar |
---|---|---|
721_B_lymphoblasts | 185.75 | |
Adipocyte | 29.3 | |
AdrenalCortex | 35.7 | |
Adrenalgland | 26.55 | |
Amygdala | 26.1 | |
Appendix | 32.5 | |
AtrioventricularNode | 27 | |
BDCA4+_DentriticCells | 85.4 | |
Bonemarrow | 37.75 | |
BronchialEpithelialCells | 59.15 | |
CD105+_Endothelial | 41.7 | |
CD14+_Monocytes | 39.6 | |
CD19+_BCells(neg._sel.) | 51.05 | |
CD33+_Myeloid | 41.25 | |
CD34+ | 41 | |
CD4+_Tcells | 42.4 | |
CD56+_NKCells | 39.45 | |
CD71+_EarlyErythroid | 52.65 | |
CD8+_Tcells | 24.95 | |
CardiacMyocytes | 88.2 | |
Caudatenucleus | 26.7 | |
Cerebellum | 46.55 | |
CerebellumPeduncles | 40.65 | |
CiliaryGanglion | 22.35 | |
CingulateCortex | 32.5 | |
Colorectaladenocarcinoma | 38.9 | |
DorsalRootGanglion | 24.3 | |
FetalThyroid | 37.4 | |
Fetalbrain | 30.5 | |
Fetalliver | 34.35 | |
Fetallung | 24.7 | |
GlobusPallidus | 23.45 | |
Heart | 49.4 | |
Hypothalamus | 21.95 | |
Kidney | 29.5 | |
Leukemia_chronicMyelogenousK-562 | 33.85 | |
Leukemia_promyelocytic-HL-60 | 57 | |
Leukemialymphoblastic(MOLT-4) | 39.4 | |
Liver | 41.9 | |
Lung | 28.3 | |
Lymphnode | 21.4 | |
Lymphoma_burkitts(Daudi) | 49.8 | |
Lymphoma_burkitts(Raji) | 51.15 | |
MedullaOblongata | 21.85 | |
OccipitalLobe | 21.55 | |
OlfactoryBulb | 36.1 | |
Ovary | 22.9 | |
Pancreas | 24.1 | |
PancreaticIslet | 30.85 | |
ParietalLobe | 33.85 | |
Pituitary | 51.35 | |
Placenta | 30.35 | |
Pons | 29.4 | |
PrefrontalCortex | 38.85 | |
Prostate | 29.8 | |
Salivarygland | 22 | |
SkeletalMuscle | 43.8 | |
Skin | 24.35 | |
SmoothMuscle | 56.2 | |
Spinalcord | 30.85 | |
SubthalamicNucleus | 25.45 | |
SuperiorCervicalGanglion | 47.35 | |
TemporalLobe | 30.6 | |
Testis | 27.2 | |
TestisGermCell | 20.2 | |
TestisIntersitial | 24.3 | |
TestisLeydigCell | 31.45 | |
TestisSeminiferousTubule | 23.6 | |
Thalamus | 28.45 | |
Thymus | 94.5 | |
Thyroid | 21.35 | |
Tongue | 31.3 | |
Tonsil | 30.3 | |
Trachea | 28.1 | |
TrigeminalGanglion | 32.45 | |
Uterus | 18.25 | |
UterusCorpus | 28.45 | |
WholeBlood | 100.95 | |
Wholebrain | 20.15 | |
colon | 101.85 | |
pineal_day | 34.66 | |
pineal_night | 36.16 | |
retina | 43.65 | |
small_intestine | 70.55 |
Human Whole Brain Microarrayview in Allen Brain Atlas
- Probe name: A_23_P3242
- Donor H0351.2001
- Sex: Male Age: 24 years Race/Ethnicity: African American Handedness: Left
- Tissue Receipt Date: 7/29/2009 Serology: Pass Tissue pH :6.72 Additional Medical Information :History of asthma
- Postmortem Interval: 23 hours (estimated time of death to time that tissue is frozen)
- Toxicology: Positive for atropine and caffeine, at levels usually not toxicologically significant
Tissue | Expression(mean ± stddev) | Expression Bar |
---|---|---|
Amygdala | 7.43 ± 0.38 | |
Basal Forebrain | 7.58 ± 0.25 | |
Basal Part of Pons | 7.33 ± 0.31 | |
Cerebellar Cortex | 7.87 ± 0.2 | |
Cerebellar Nuclei | 7.47 ± 0.27 | |
Claustrum | 7.06 ± 0.41 | |
Epithalamus | 7.56 ± 0.25 | |
Frontal Lobe | 7.52 ± 0.29 | |
Globus Pallidus | 7.36 ± 0.36 | |
Hypothalamus | 7.23 ± 0.23 | |
Insula | 7.59 ± 0.33 | |
Limbic Lobe | 7.65 ± 0.31 | |
Mesencephalon | 7.49 ± 0.34 | |
Myelencephalon | 7.53 ± 0.36 | |
Occipital Lobe | 7.8 ± 0.26 | |
Parietal Lobe | 7.49 ± 0.35 | |
Pontine Tegmentum | 7.55 ± 0.34 | |
Striatum | 7.88 ± 0.41 | |
Subthalamus | 7.64 ± 0.1 | |
Temporal Lobe | 7.51 ± 0.24 | |
Thalamus | 7.5 ± 0.28 | |
White Matter | 7.08 ± 0.2 |
Gene Symbol | Brain Structure ID | Brain Structure Name | Express Desity/Level (Meatured by ISH) | Express Bar |
---|---|---|---|---|
Anp32a | CB | Cerebellum | 26.19 | |
22.41 | ||||
Anp32a | CTX | Cerebral cortex | 26.73 | |
20 | ||||
Anp32a | HIP | Hippocampal region | 20.43 | |
14.05 | ||||
Anp32a | HPF | Hippocampal formation | 19.72 | |
15.58 | ||||
Anp32a | HY | Hypothalamus | 2.14 | |
1.36 | ||||
Anp32a | LSX | Lateral septal complex | 11.58 | |
8.18 | ||||
Anp32a | MB | Midbrain | 6.52 | |
6.44 | ||||
Anp32a | MY | Medulla | 22.06 | |
20.71 | ||||
Anp32a | OLF | Olfactory bulb | 29.72 | |
18.46 | ||||
Anp32a | P | Pons | 9.13 | |
8.03 | ||||
Anp32a | PAL | Pallidum | 4.28 | |
3.4 | ||||
Anp32a | RHP | Retrohippocampal region | 19.71 | |
16.62 | ||||
Anp32a | sAMY | Striatum-like amygdalar nuclei | 4.62 | |
2.58 | ||||
Anp32a | STR | Striatum | 8.21 | |
5.54 | ||||
Anp32a | STRd | Striatum dorsal region | 5.74 | |
3.97 | ||||
Anp32a | STRv | Striatum ventral region | 16.16 | |
10.16 | ||||
Anp32a | TH | Thalamus | 5.88 | |
4.03 |
Peptide Name | Peptide Lengh | Peptide Start | Peptide End | Peptide Sequence | Source |
---|---|---|---|---|---|
AN32A_HUMAN_0 | 0 | 0 | 0 | DLSTIEPLK | PRIDE |
AN32A_HUMAN_0 | 0 | 0 | 0 | LLPQLTYLDGYDR | PRIDE |
AN32A_HUMAN_0 | 0 | 0 | 0 | SLDLFNCEVTNLNDYR | PRIDE |
AN32A_HUMAN_0 | 0 | 0 | 0 | VSGGLEVLAEK | PRIDE |
AN32A_HUMAN_101 | 10 | 101 | 110 | DLSTIEPLKK | PRIDE |
AN32A_HUMAN_101 | 15 | 101 | 115 | DLSTIEPLKKLENLK | PRIDE |
AN32A_HUMAN_101 | 9 | 101 | 109 | DLSTIEPLK | PRIDE |
AN32A_HUMAN_116 | 16 | 116 | 131 | SLDLFNCEVTNLNDYR | PRIDE |
AN32A_HUMAN_116 | 21 | 116 | 136 | SLDLFNCEVTNLNDYRENVFK | PRIDE |
AN32A_HUMAN_137 | 13 | 137 | 149 | LLPQLTYLDGYDR | PRIDE |
AN32A_HUMAN_137 | 16 | 137 | 152 | LLPQLTYLDGYDRDDK | PRIDE |
AN32A_HUMAN_16 | 13 | 16 | 28 | PSDVKELVLDNSR | PRIDE |
AN32A_HUMAN_20 | 8 | 20 | 27 | ELVLDNSR | PRIDE |
AN32A_HUMAN_75 | 11 | 75 | 85 | VSGGLEVLAEK | PRIDE |
AN32A_HUMAN_75 | 24 | 75 | 98 | VSGGLEVLAEKCPNLTHLNLSGNK | PRIDE |
AN32A_HUMAN_86 | 13 | 86 | 98 | CPNLTHLNLSGNK | PRIDE |
PAp00001270 | 13 | 87 | 99 | CPNLTHLNLSGNK | Peptide Atlas |